Press Releases - 2023-01-03

Date	Title	Company
03-Jan-2023	Molecure Appoints Dr. Samson Fung, Chief Medical Officer to its Management Board as it Continues to Focus on Successfully Progressing its Expanded Clinical Portfolio	Molecure
03-Jan-2023	Senior appointments at Copley signal the start of a new phase of growth	Copley
03-Jan-2023	Evaxion receives approval from FDA to proceed with the clinical Phase 2b study for EVX-01	Evaxion Biotech
03-Jan-2023	Alphalyse and Bavarian Nordic A/S significantly shorten the time necessary to document HCP impurities in COVID-19 vaccine candidate for Phase 3 clinical trial – through world’s first MS-based HCP analysis under GMP conditions	Alphalyse
03-Jan-2023	Dante Genomics to present at the 41st Annual J.P. Morgan Healthcare Conference	Dante Genomics
03-Jan-2023	Tiziana Life Sciences Announces Additional Clinical Improvements in the Second Patient with Non-Active Secondary Progressive Multiple Sclerosis (SPMS) After Eleven Months of Dosing with Intranasal Foralumab	Tiziana Life Sciences
03-Jan-2023	iTeos to Present at the 41st Annual J.P. Morgan Healthcare Conference	iTeos Therapeutics
03-Jan-2023	PharmaSGP Holding SE resolves on buyback program for own shares of up to 1.5 million Euro	PharmaSGP Holding SE
03-Jan-2023	Anatomic Pathology Market to achieve CAGR of 6.1% by 2032, owing to increasing incidence of cancer and other diseases \| insightSLICE	insightSLICE
03-Jan-2023	Primary Cell Market exhibiting CAGR of 9.2% by 2032, owing to rising investments in regenerative medicine research \| insightSLICE	insightSLICE
03-Jan-2023	Medical Cannula Market exhibiting CAGR of 7.2% by 2032, owing to increasing cases of diabetes & obesity \| insightSLICE	insightSLICE
03-Jan-2023	Disposable Bronchoscopes Market exhibiting CAGR of 11.3% from 2023 to 2032, owing to growing demand for local biopsies \| insightSLICE	insightSLICE
03-Jan-2023	Diketene Market is geared to grow at a CAGR of 4.3% through 2032 \| insightSLICE	insightSLICE
03-Jan-2023	Cannabis Inhaler Market is anticipated to expand at a CAGR of 7.2% from 2023 to 2032 \| insightSLICE	insightSLICE
03-Jan-2023	Astex Co-founder and CEO Harren Jhoti Awarded OBE in the King’s New Year Honours	Astex Pharmaceuticals
03-Jan-2023	HUTCHMED Completes Patient Enrollment of ESLIM-01, a Phase III Trial of Sovleplenib in Primary Immune Thrombocytopenia in China	HUTCHMED
03-Jan-2023	Drägerwerk AG & Co. KGaA: Dräger redeems last participation certificates – streamlining of capital structure completed	Drägerwerk AG & Co. KGaA
03-Jan-2023	Newron announces striking six-month interim results from its exploratory clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia	Newron Pharmaceuticals S.p.A.